User: Guest  Login
Title:

Keynote-365 cohort a: Pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC).

Document type:
Meeting Abstract
Author(s):
Yu, Evan Y.; Massard, Christophe; Retz, Margitta; Tafreshi, Ali; Carles Galceran, Joan; Hammerer, Peter; Fong, Peter C. C.; Shore, Neal D.; Joshua, Anthony; Linch, Mark David; Gurney, Howard; Romano, Emanuela; Augustin, Marinela; Piulats, Josep M.; Wu, Haiyan; Schloss, Charles; Poehlein, Christian Heinrich; De Bono, Johann S.
Journal title abbreviation:
J Clin Oncol
Year:
2019
Journal volume:
37 Suppl S
Journal issue:
7
Fulltext / DOI:
doi:10.1200/JCO.2019.37.7_suppl.145
Print-ISSN:
0732-183X
TUM Institution:
Urologische Klinik und Poliklinik
 BibTeX